Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ludaterone acetate
- Development stage
- Unknown
- Lead developer
- ASKA Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
AKP-009 (ludaterone acetate) is a small molecule steroidal anti-androgen developed by ASKA Pharmaceutical in collaboration with Kyorin Pharmaceutical. It acts as a potent antagonist of the androgen receptor, blocking the binding of testosterone and dihydrotestosterone (DHT) to their receptors. The drug is primarily being developed for the treatment of benign prostatic hyperplasia (BPH), where it aims to reduce prostate volume and alleviate lower urinary tract symptoms. Additionally, it is being investigated for the treatment of polycystic ovary syndrome (PCOS) to manage symptoms associated with hyperandrogenism. As of early 2026, ludaterone acetate is in Phase 3 clinical trials for BPH and is in the preparation stage for clinical trials in PCOS.
- Other names
- Saldrosterone acetate
02
Targets
AR (Adrenergic receptors)
Beyond the preview
Go deeper on ludaterone acetate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ludaterone acetate.